// App-Quantinova.ai

142 : Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

Researchers

Presenter

  • Charlene Mantia

Principal Investigators

  • Erik Uhlmann

  • Maneka Puligandla

  • Donna S. Neuberg

  • Griffin M. Weber

  • Jeffrey I. Zwicker

Medical Centers

  • Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

  • Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA

  • Interdisciplinary Medicine and Biotechnology, Beth Israel Deaconess Medical Center and Center for Biomedical Informatics, Boston, MA

  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Brain cancer

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved